Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man [14]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 7, 2006, Pages 887-889

  Ghislanzoni, Max ^a   Cusini, M ^a   Zerboni, R ^a   Alessi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CIDOFOVIR; FOSCARNET; VALACICLOVIR;

ADULT; BIOPSY; CASE REPORT; GENITAL HERPES; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTROPHY; INGUINAL LYMPH NODE; LETTER; LYMPHADENOPATHY; MALE; NEPHROTOXICITY; NONHUMAN; PREPUCE; PRIORITY JOURNAL; RECURRENT DISEASE; SCROTUM DISORDER; ULCER; VIRUS LOAD;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CHRONIC DISEASE; CYTOSINE; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FOSCARNET; HERPES GENITALIS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS;

EID: 33746309753     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01561.x     Document Type: Letter

References (10)

1. Severson JL, Tyring SK. Relation between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999; 135: 1393-1397.
2. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26: 29-37.
3. Vogel P, Smith KJ, Skeleton HG, Cuozzo D, Wagner KF. Verrucous lesions of herpes simplex in HIV-1+ patients. Military Medical Consortium for the Advancement of Retroviral Research. Int J Dermatol 1993; 32: 680-682.
4. Beasley KL, Cooley GE, Kao GF, Lowitt MH, Burnett JW, Aurelian L. Herpes simplex vegetans: Atypical genital herpes infection in a patient with common variable immunodeficiency. J Am Acad Dermatol 1997; 37: 860-863.
5. Samaratunga H, Weedon D, Musgrave N, McCallum N. Atypical presentation of herpes simplex (chronic hypertrophic herpes) in a patient with HIV infection. Pathology 2001; 33: 532-535.
6. Fangman WL, Rao CH, Myers SA. Hypertrophic herpes simplex virus in HIV patients. J Drugs Dermatol 2003; 2: 198-201.
7. Fox PA, Barton SE, Francis N et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1999; 1: 10-18.
8. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 1994; 169: 1338-1341.
9. Pechère M, Wunderli W, Trellu-Toutous L, Harms M, Saurat JH, Krischer J. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis. Dermatology 1998; 197: 278-280.
10. Bevilacqua F, Marcello A, Toni M et al. Acyclovir resistance/ susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. J Acquir Immune Defic Syndr 1991; 4: 967-969.